Mercy P D, Ravindranath M H
Department of Zoology, Holy Cross College, Tamilnadu, India.
Experientia. 1992 May 15;48(5):498-500. doi: 10.1007/BF01928173.
A novel agglutinin with specificity for sialic acid sequence of sugars in thyroglobulin is identified in the hemolymph of Scylla serrata. The physico-chemical characteristics of its binding affinity, such as pH and temperature optima, and cationic requirements are defined. N-glycolyl neuraminic acid (NeuGc) (at 0.6 mM), in contrast to N-acetyl neuraminic acid (NeuAc) (at greater than 5.0 mM), is the potent inhibitor of hemagglutination. Bovine and porcine thyroglobulins containing NeuGc, inhibited the agglutination. NeuGc-acid glycoprotein fraction (bovine) but not NeuAc-acid glycoprotein fraction (human) inhibited the hemagglutination. The inability of other NeuGc-glycoproteins (bovine submaxillary mucin) to inhibit the agglutination suggests that the agglutinin may also recognize glycosidic linkage associated with NeuGc. The potential of the agglutinin in identifying NeuGc containing human tumor associated antigens is discussed.
在锯缘青蟹的血淋巴中鉴定出一种对甲状腺球蛋白中糖的唾液酸序列具有特异性的新型凝集素。定义了其结合亲和力的物理化学特性,如最适pH和温度以及阳离子需求。与N-乙酰神经氨酸(NeuAc)(浓度大于5.0 mM)相比,N-糖基神经氨酸(NeuGc)(0.6 mM)是血凝的有效抑制剂。含有NeuGc的牛和猪甲状腺球蛋白可抑制凝集。NeuGc-酸性糖蛋白组分(牛)而非NeuAc-酸性糖蛋白组分(人)可抑制血凝。其他NeuGc-糖蛋白(牛颌下粘蛋白)无法抑制凝集,这表明该凝集素可能还识别与NeuGc相关的糖苷键。讨论了该凝集素在鉴定含NeuGc的人类肿瘤相关抗原方面的潜力。